Growth hormone secretion after baclofen administration in different phases of the menstrual cycle in healthy women

Horm Res. 2001;55(3):131-6. doi: 10.1159/000049984.

Abstract

Aim: The aim of this study was to investigate the effect of baclofen administration on growth hormone (GH) secretion during different phases of the menstrual cycle.

Methods: Twelve healthy women (33.6 +/- (SD) 2.8 years; range 23-40 years) with regular menstrual cycles were enrolled. The phases of the menstrual cycle were determined using transvaginal ultrasonography (TV-US) and detecting hormonal serum levels. Plasma GH levels were evaluated during the early follicular, periovulatory and luteal phases of the cycle before and after the baclofen challenge test.

Results: After acute baclofen administration, GH levels increased significantly (p < 0.001) compared to basal values during the periovulatory and luteal phases, while no significant variation was detected during the early follicular phase. In addition, plasma GH levels resulted significantly (p < 0.001) higher during the luteal phase than during the periovulatory phase.

Conclusion: Acute baclofen administration induces a significant increase in plasma GH levels in healthy females during the periovulatory and luteal phases, but not during the early follicular phase. These data suggest a modulator role of plasma sex steroids levels on GH release induced by baclofen.

MeSH terms

  • Administration, Oral
  • Adult
  • Baclofen / administration & dosage*
  • Baclofen / pharmacology
  • Female
  • Follicular Phase / drug effects
  • GABA Agonists / administration & dosage
  • GABA Agonists / pharmacology
  • Growth Hormone / blood
  • Growth Hormone / metabolism*
  • Humans
  • Luteal Phase / drug effects
  • Menstrual Cycle / blood
  • Menstrual Cycle / drug effects*
  • Ovulation / drug effects

Substances

  • GABA Agonists
  • Growth Hormone
  • Baclofen